Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Positive CHMP opinion in EU for saxa/dapa (saxagliptin and dapagliflozin) for adults with type-2 diabetes
-
AstraZeneca receives Complete Response Letter from US FDA for sodium zirconium cyclosilicate (ZS-9) for oral suspension for treatment of hyperkalaemia
-
AstraZeneca highlights continued progress of oncology pipeline at 2016 ASCO Annual Meeting
-
AstraZeneca provides top-line results from Lynparza GOLD trial in advanced gastric cancer
-
AstraZeneca announces positive results from benralizumab phase III programme in severe asthma
-
Selumetinib granted Orphan Drug Designation in the US for adjuvant treatment of differentiated thyroid cancer
-
AstraZeneca to highlight the breadth of its respiratory medicines at American Thoracic Society 2016 International Conference
-
AstraZeneca completes divestment of Imdur to China Medical System Holdings
-
AstraZeneca completes acquisition of Takeda’s respiratory business
-
Q1 2016 Results
Latest articles and press releases
All of our latest press releases and articles are available to explore
